Luspatercept for Clonal Cytopenias of Uncertain Significance
Luspatercept for Clonal Cytopenias of Uncertain Significance
Recruiting · NCT06788691 · Registry updated 2026-03-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Luspatercept for Clonal Cytopenias of Uncertain Significance | Cytopenia, Hemic and Lymphatic Diseases, agranulocytosis, anemia, blood platelet disease, hematologic disorder, leukocyte disorder, leukopenia, neutropenia, thrombocytopenia | Recruiting | Phase 2 | 2026-03-24 | NCT06788691 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bristol-Myers Squibb | 422 |
| Weill Medical College of Cornell University | 276 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Weill Cornell Medical College | New York | United States | 35 |